Quantitative analysis revealed that the number of Xgal+cells within implantation sites decreased between 3 days and 7 days, suggesting limited durability of organoid engraftment (Figure 5B). compared organoid engraftment to that of single-cell hepatocyte transplants. In addition , we determined the effect of adding stellate cells to hepatocytes to form co-aggregated organoids and the effect of partial hepatectomy of the host liver on organoid engraftment. == Results == Direct orthotopic implantation of hepatic organoids within a hepatotomy site resulted in local engraftment of exogenous hepatocytes with limited durability. Hepatocyte-stellate cell organoids produced more extracellular matrix but did not significantly improve engraftment compared to hepatocyte-alone organoids. Partial hepatectomy of the host liver led to significantly decreased engraftment of organoids. Survival of organoids was limited by the presence of apoptotic hepatocytes within organoids as early as 1 hour after implantation. Organoids eventually became necrotic and elicited a chronic inflammatory giant cell reaction similar to a foreign body response. == Conclusion == With additional organoid and host factor optimization, direct orthotopic implantation of hepatic organoids may be an approach to introduce large numbers of exogenous hepatocytes into recipient livers. Keywords: Liver organoids, Three-dimensional culture, Transplantation, Tissue engineering == Introduction == Organoids are three-dimensional (3D) aggregates of organ-specific cells that self-organizein vitrointoin vivo-like tissue structures. Recent advances have led to the generation of retinal, brain, kidney, gut, and liver organoids that recapitulate some of the specific functions of those organs. Importantly, organoids have great therapeutic potential if effective implantation strategies can be developed for organoids to replace diseased or dysfunctional organs in Rabbit Polyclonal to IL4 humans. 1 Liver transplantation is currently the only treatment for end-stage liver disease, which is the 12thleading cause of death by disease in the United States. 2Transplantation is limited by the severe shortage of donor organs and there is a critical need to develop alternative approaches to replace lost liver function. Human liver organoids have been developed from induced pluripotent Taranabant stem cells3and adult bipotential liver stem cells4by culturing in extracellular matrix (ECM) Taranabant produced by Engelbreth-Holm-Swarm mouse sarcoma cells (marketed under the tradename Matrigel). While initial efforts to implant liver organoids into mouse models showed promising results, they remain limited in that either engraftment sites were ectopic (e. g. brain, kidney capsule, or mesentery)3or engraftment efficiency into the liver was low. 4In addition, engraftment required genetically engineered mouse models3, 5or pre-treatment with toxins4that conferred a proliferative advantage to implanted cells over endogenous hepatocytes, conditions that could not be recapitulated easily clinically. Implantation experiments were conducted in severely immunodeficient mice35and likely do not reflect the immunological reaction that would be elicited in a clinical scenario in humans. Finally, dependence on Matrigel for organoid formation is problematic because Matrigel is a collection of undefined protein products from a xenogenic source that cannot easily be translated into clinical applications. Our lab has generated liver organoids in rotating wall vessel (RWV) bioreactors that provide an unencumbered 3D Taranabant spatial environment for cells to self-aggregate and self-organize. 6, 7This approach has the advantage of efficiently producing bulk cultures of organoids that initiate cellular self-organization in a 3D environment, as opposed to Matrigel-based methods that coax development of 3D structures from a two-dimensional (2D) surface. Moreover, formation of organoids in RWVs does not rely on Matrigel. RWVs produce solid-body rotation with laminar flow, resulting in an idealized suspension culture with low turbulence, low shear stress, and maximal 3D spatial freedom for cells to self-associate. 8These Taranabant unique features promote formation of larger aggregates that have decreased hypoxia near the core compared to stationary methods. 9Organoids that mimic thein vivoarchitecture of numerous organs, including lung, intestine, bladder, and liver, have been successfully generated in RWVs. 10Hepatocytes that self-aggregate within RWVs form tight junctions and bile canaliculi11and display differentiated characteristics that make them good models to Taranabant study hepatitis C host-pathogen interactions. 12Our lab has shown that compared to 2D culture, hepatic organoids generated in RWVs have significantly greater hepatocyte-specific.